Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
53
PharmaCompass offers a list of Ampicillin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ampicillin Sodium manufacturer or Ampicillin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ampicillin Sodium manufacturer or Ampicillin Sodium supplier.
PharmaCompass also assists you with knowing the Ampicillin Sodium API Price utilized in the formulation of products. Ampicillin Sodium API Price is not always fixed or binding as the Ampicillin Sodium Price is obtained through a variety of data sources. The Ampicillin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AMPICILLIN AND SULBACTAM manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AMPICILLIN AND SULBACTAM, including repackagers and relabelers. The FDA regulates AMPICILLIN AND SULBACTAM manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AMPICILLIN AND SULBACTAM API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AMPICILLIN AND SULBACTAM manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AMPICILLIN AND SULBACTAM supplier is an individual or a company that provides AMPICILLIN AND SULBACTAM active pharmaceutical ingredient (API) or AMPICILLIN AND SULBACTAM finished formulations upon request. The AMPICILLIN AND SULBACTAM suppliers may include AMPICILLIN AND SULBACTAM API manufacturers, exporters, distributors and traders.
click here to find a list of AMPICILLIN AND SULBACTAM suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AMPICILLIN AND SULBACTAM DMF (Drug Master File) is a document detailing the whole manufacturing process of AMPICILLIN AND SULBACTAM active pharmaceutical ingredient (API) in detail. Different forms of AMPICILLIN AND SULBACTAM DMFs exist exist since differing nations have different regulations, such as AMPICILLIN AND SULBACTAM USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AMPICILLIN AND SULBACTAM DMF submitted to regulatory agencies in the US is known as a USDMF. AMPICILLIN AND SULBACTAM USDMF includes data on AMPICILLIN AND SULBACTAM's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AMPICILLIN AND SULBACTAM USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AMPICILLIN AND SULBACTAM suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The AMPICILLIN AND SULBACTAM Drug Master File in Japan (AMPICILLIN AND SULBACTAM JDMF) empowers AMPICILLIN AND SULBACTAM API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the AMPICILLIN AND SULBACTAM JDMF during the approval evaluation for pharmaceutical products. At the time of AMPICILLIN AND SULBACTAM JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of AMPICILLIN AND SULBACTAM suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a AMPICILLIN AND SULBACTAM Drug Master File in Korea (AMPICILLIN AND SULBACTAM KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of AMPICILLIN AND SULBACTAM. The MFDS reviews the AMPICILLIN AND SULBACTAM KDMF as part of the drug registration process and uses the information provided in the AMPICILLIN AND SULBACTAM KDMF to evaluate the safety and efficacy of the drug.
After submitting a AMPICILLIN AND SULBACTAM KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their AMPICILLIN AND SULBACTAM API can apply through the Korea Drug Master File (KDMF).
click here to find a list of AMPICILLIN AND SULBACTAM suppliers with KDMF on PharmaCompass.
A AMPICILLIN AND SULBACTAM CEP of the European Pharmacopoeia monograph is often referred to as a AMPICILLIN AND SULBACTAM Certificate of Suitability (COS). The purpose of a AMPICILLIN AND SULBACTAM CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of AMPICILLIN AND SULBACTAM EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of AMPICILLIN AND SULBACTAM to their clients by showing that a AMPICILLIN AND SULBACTAM CEP has been issued for it. The manufacturer submits a AMPICILLIN AND SULBACTAM CEP (COS) as part of the market authorization procedure, and it takes on the role of a AMPICILLIN AND SULBACTAM CEP holder for the record. Additionally, the data presented in the AMPICILLIN AND SULBACTAM CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the AMPICILLIN AND SULBACTAM DMF.
A AMPICILLIN AND SULBACTAM CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. AMPICILLIN AND SULBACTAM CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of AMPICILLIN AND SULBACTAM suppliers with CEP (COS) on PharmaCompass.
A AMPICILLIN AND SULBACTAM written confirmation (AMPICILLIN AND SULBACTAM WC) is an official document issued by a regulatory agency to a AMPICILLIN AND SULBACTAM manufacturer, verifying that the manufacturing facility of a AMPICILLIN AND SULBACTAM active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting AMPICILLIN AND SULBACTAM APIs or AMPICILLIN AND SULBACTAM finished pharmaceutical products to another nation, regulatory agencies frequently require a AMPICILLIN AND SULBACTAM WC (written confirmation) as part of the regulatory process.
click here to find a list of AMPICILLIN AND SULBACTAM suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AMPICILLIN AND SULBACTAM as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AMPICILLIN AND SULBACTAM API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AMPICILLIN AND SULBACTAM as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AMPICILLIN AND SULBACTAM and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AMPICILLIN AND SULBACTAM NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AMPICILLIN AND SULBACTAM suppliers with NDC on PharmaCompass.
AMPICILLIN AND SULBACTAM Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AMPICILLIN AND SULBACTAM GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AMPICILLIN AND SULBACTAM GMP manufacturer or AMPICILLIN AND SULBACTAM GMP API supplier for your needs.
A AMPICILLIN AND SULBACTAM CoA (Certificate of Analysis) is a formal document that attests to AMPICILLIN AND SULBACTAM's compliance with AMPICILLIN AND SULBACTAM specifications and serves as a tool for batch-level quality control.
AMPICILLIN AND SULBACTAM CoA mostly includes findings from lab analyses of a specific batch. For each AMPICILLIN AND SULBACTAM CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AMPICILLIN AND SULBACTAM may be tested according to a variety of international standards, such as European Pharmacopoeia (AMPICILLIN AND SULBACTAM EP), AMPICILLIN AND SULBACTAM JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AMPICILLIN AND SULBACTAM USP).
